Invesco S&P SmallCap 600 Pure Growth ETF
- ETF
- Ticker RZG
- NYSE
Performance, volatility and drawdowns of Invesco S&P SmallCap 600 Pure Growth ETF since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $19,650. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −54.0% in 03/2020, measured from the peak in 08/2018. It took 28 months to get back to the old peak.
Factor profile
Monthly returns 12/2016 to 09/2026, measured against USA. The factors explain 91% of the variation.
- Market
- 1.10
- Size
- 1.03
- Value
- 0.14
- Profitability
- 0.07
- Low investment
- −0.09
- Momentum
- 0.26
How to read this: RZG moves about as much as the stock market (USA). The ETF leans towards small companies and stocks that have done well recently.
A value of 1 for the market means: when the market rises by 1%, the ETF rises by 1% on average. The other values show the lean towards small, cheaply valued, profitable, conservatively investing and recently strong stocks; bold where it is clear. Calculated with the Fama and French factors and momentum.
Annual returns
Best year 2021 at +21.0%, weakest 2022 at −29.0%. 7 of 9 full years were positive. * partial year.
Similar ETFs
Frequently asked questions
How has RZG performed since 11/2016?
$10,000 grew to $19,650 by 20 Nov 2026, which is +7.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is RZG?
Volatility was 22.9% per year, measured on monthly returns. The largest decline from a peak was −54.0%, with the low in 03/2020.
How does RZG compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, RZG returned +7.0% at 22.9%. The correlation of monthly returns was 0.85; 1 would mean they moved in lockstep.
What does RZG hold?
RZG holds 126 positions. The largest are ACM Research, Inc., A Shares, Dave Inc. and Protagonist Therapeutics, Inc.; the 10 largest together make up 17.2% of the fund (holdings as of 31 Jul 2026, according to the fund's filing with the SEC).
Which currency are the figures in?
In US dollars, the currency of the US listing.